Herbas VPB

Print
EN | LT
Supplementary protection
LT - Dvigubai specifiniai anti-VEGF/anti-ANG-2 antikūnai ir jų panaudojimas akių kraujagyslių ligoms gydyti
EN - BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES
SPC
(11) Number of the document C 2872534
(68) Number of the document 2872534
(21) Application number for Supplementary Protection Certificate PA 2023 507
(22) Date of filing the application 2023-02-14
(41) Date of publication of the application 2023-03-10
Date of publication of SPC 2024-10-25
(24) Date of coming into effect of SPC 2033-07-12
Applicant
(71) F. Hoffmann-La Roche AG , Grenzacherstrasse 124, 4070 Basel, CH
Grantee
(73) F. Hoffmann-La Roche AG , Grenzacherstrasse 124, 4070 Basel, CH
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/22/1683, 2022-09-15
Calculated date of expiry of the SPC
(94) 2037-09-16
Name of the product protected by the basic patent
(95) Faricimabas
Legal status
SPC granted
Last update date 2024-10-24